Simone Meini1, Alberto Fortini2, Roberto Andreini3, Leonardo Alberto Sechi4, Carlo Tascini5. 1. UOC Medicina Interna, Ospedale Santa Maria Annunziata, Firenze, Italy. 2. UOC Medicina Interna, Ospedale Nuovo San Giovanni di Dio, Firenze, Italy. 3. UOC Medicina Interna, Ospedale Felice Lotti, Pontedera, Italy. 4. Clinica Medica, Ospedale Santa Maria Misericordia, Udine, Italy. 5. SOC Malattie Infettive, Ospedale Santa Maria Misericordia, Udine, Italy.
Abstract
INTRODUCTION: COVID-19, a respiratory illness due to SARS-CoV-2 coronavirus, was first described in December 2019 in Wuhan, rapidly evolving into a pandemic. Smoking increases the risk of respiratory infections; thus, cessation represents a huge opportunity for public health. However, there is scarce evidence about if and how smoking affects the risk of SARS-CoV-2 infection. METHODS: We performed an observational case-control study, assessing the single-day point prevalence of smoking among 218 COVID-19 adult patients hospitalized in seven Italian nonintensive care wards and in a control group of 243 patients admitted for other conditions to seven COVID-19-free general wards. We compared proportions for categorical variables by using the χ 2 test and performed univariate and multivariate logistic regression analyses to identify the variables associated with the risk of hospitalization for COVID-19. RESULTS: The percentages of current smokers (4.1% vs 16%, p = .00003) and never smokers (71.6% vs 56.8%, p = .0014) were significantly different between COVID-19 and non-COVID 19 patients. COVID-19 patients had lower mean age (69.5 vs 74.2 years, p = .00085) and were more frequently males (59.2% vs 44%, p = .0011). In the logistic regression analysis, current smokers were significantly less likely to be hospitalized for COVID-19 compared with nonsmokers (odds ratio = 0.23; 95% confidence interval, 0.11-0.48, p < .001), even after adjusting for age and gender (odds ratio = 0.14; 95% confidence interval, 0.06-0.31, p < .001). CONCLUSIONS: We reported an unexpectedly low prevalence of current smokers among COVID-19 patients hospitalized in nonintensive care wards. The meaning of these preliminary findings, which are in line with those currently emerging in literature, is unclear; they need to be confirmed by larger studies. IMPLICATIONS: An unexpectedly low prevalence of current smokers among patients hospitalized for COVID-19 in some Italian nonintensive care wards is reported. This finding could be a stimulus for the generation of novel hypotheses on individual predisposition and possible strategies for reducing the risk of infection from SARS-CoV-2 and needs to be confirmed by further larger studies designed with adequate methodology.
INTRODUCTION:COVID-19, a respiratory illness due to SARS-CoV-2coronavirus, was first described in December 2019 in Wuhan, rapidly evolving into a pandemic. Smoking increases the risk of respiratory infections; thus, cessation represents a huge opportunity for public health. However, there is scarce evidence about if and how smoking affects the risk of SARS-CoV-2 infection. METHODS: We performed an observational case-control study, assessing the single-day point prevalence of smoking among 218 COVID-19 adult patients hospitalized in seven Italian nonintensive care wards and in a control group of 243 patients admitted for other conditions to seven COVID-19-free general wards. We compared proportions for categorical variables by using the χ 2 test and performed univariate and multivariate logistic regression analyses to identify the variables associated with the risk of hospitalization for COVID-19. RESULTS: The percentages of current smokers (4.1% vs 16%, p = .00003) and never smokers (71.6% vs 56.8%, p = .0014) were significantly different between COVID-19 and non-COVID 19patients. COVID-19patients had lower mean age (69.5 vs 74.2 years, p = .00085) and were more frequently males (59.2% vs 44%, p = .0011). In the logistic regression analysis, current smokers were significantly less likely to be hospitalized for COVID-19 compared with nonsmokers (odds ratio = 0.23; 95% confidence interval, 0.11-0.48, p < .001), even after adjusting for age and gender (odds ratio = 0.14; 95% confidence interval, 0.06-0.31, p < .001). CONCLUSIONS: We reported an unexpectedly low prevalence of current smokers among COVID-19patients hospitalized in nonintensive care wards. The meaning of these preliminary findings, which are in line with those currently emerging in literature, is unclear; they need to be confirmed by larger studies. IMPLICATIONS: An unexpectedly low prevalence of current smokers among patients hospitalized for COVID-19 in some Italian nonintensive care wards is reported. This finding could be a stimulus for the generation of novel hypotheses on individual predisposition and possible strategies for reducing the risk of infection from SARS-CoV-2 and needs to be confirmed by further larger studies designed with adequate methodology.
Authors: Samuel D Johnson; Omalla A Olwenyi; Namita Bhyravbhatla; Michellie Thurman; Kabita Pandey; Elizabeth A Klug; Morgan Johnston; Shetty Ravi Dyavar; Arpan Acharya; Anthony T Podany; Courtney V Fletcher; Mahesh Mohan; Kamal Singh; Siddappa N Byrareddy Journal: World J Gastroenterol Date: 2021-08-07 Impact factor: 5.742
Authors: Evgenii M Kozlov; Ekaterina Ivanova; Andrey V Grechko; Wei-Kai Wu; Antonina V Starodubova; Alexander N Orekhov Journal: Diseases Date: 2021-02-24
Authors: Makoto Miyara; Florence Tubach; Valérie Pourcher; Capucine Morélot-Panzini; Julie Pernet; Julien Haroche; Said Lebbah; Elise Morawiec; Guy Gorochov; Eric Caumes; Pierre Hausfater; Alain Combes; Thomas Similowski; Zahir Amoura Journal: Front Med (Lausanne) Date: 2022-01-05
Authors: Paola Mariela Saba Villarroel; María Del Rosario Castro Soto; Verónica Undurraga; Heydi Sanz; Ana María Jaldín; Laetitia Ninove; Elif Nurtop; Laura Pezzi; Souand Mohamed Ali; Abdennour Amroun; Morgan Seston; Xavier de Lamballerie Journal: Viruses Date: 2022-01-25 Impact factor: 5.048